Downregulation of HP1α suppresses proliferation of cholangiocarcinoma by restoring SFRP1 expression

Wenlong Cheng; Li Tian; Bing Wang; Yongqiang Qi; Wenhua Huang; Hongbo Li; Yong-Jun Chen

doi:10.18632/oncotarget.10371

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Downregulation of HP1α suppresses proliferation of cholangiocarcinoma by restoring SFRP1 expression

Wenlong Cheng, Li Tian, Bing Wang, Yongqiang Qi, Wenhua Huang, Hongbo Li and Yong-Jun Chen _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:48107-48119. https://doi.org/10.18632/oncotarget.10371

Metrics: PDF 2357 views | HTML 2498 views | ?

Abstract

Wenlong Cheng1,*, Li Tian2,*, Bing Wang1, Yongqiang Qi1, Wenhua Huang1, Hongbo Li3, Yong-Jun Chen1

1Department of Biliary-Pancreatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China

2Department of Wuhan Medical Care Center for Women and Children, Wuhan, Hubei Province, China

3Department of Hepatobiliary Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, China

*These authors contributed equally to this work

Correspondence to:

Yong-Jun Chen, email: [email protected]

Keywords: HP1α, cholangiocarcinoma, proliferation, SFRP1, DNA methylation

Received: January 26, 2016 Accepted: June 12, 2016 Published: July 01, 2016

ABSTRACT

Heterochromatin protein 1α (HP1α) is a gene that mediates chromatin conformation, gene silencing and cancer progression. However, little is known regarding the impact of HP1α in the pathogenesis of cholangiocarcinoma (CCA). In the present study, we demonstrate that HP1α is significantly upregulated in CCA tissues and cell lines, while downregulation of HP1α leads to suppression of cell proliferation. Then we find that downregulation of HP1α can decrease H3K9me3 enrichment and DNA methylation rate of secreted frizzled-related protein 1 (SFRP1) promoter, resulting in restoring the expression of SFRP1. Moreover, restoration of SFRP1 expression can suppress CCA cells proliferation. These results provide a mechanistic understanding of the role of HP1α in the pathogenesis of CCA and may offer a novel therapeutic target in this disease.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10371

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Downregulation of HP1α suppresses proliferation of cholangiocarcinoma by restoring SFRP1 expression

Abstract